NeoRich BioPharma Tech Statistics
Total Valuation
NRBP has a market cap or net worth of 127,933.
| Market Cap | 127,933 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
NRBP has 345,672 shares outstanding.
| Current Share Class | 345,672 |
| Shares Outstanding | 345,672 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 42.62 |
| PB Ratio | -0.05 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04
| Current Ratio | 0.04 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -10.69 |
| Interest Coverage | -7.09 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -139.13% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 10.15% |
| Weighted Average Cost of Capital (WACC) | 9.01% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.03 |
| Inventory Turnover | 0.20 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.50% in the last 52 weeks. The beta is 1.67, so NRBP's price volatility has been higher than the market average.
| Beta (5Y) | 1.67 |
| 52-Week Price Change | -81.50% |
| 50-Day Moving Average | 1.60 |
| 200-Day Moving Average | 3.35 |
| Relative Strength Index (RSI) | 34.86 |
| Average Volume (20 Days) | 1,222 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, NRBP had revenue of 3,002 and -226,257 in losses. Loss per share was -0.68.
| Revenue | 3,002 |
| Gross Profit | 1,348 |
| Operating Income | -234,387 |
| Pretax Income | -226,292 |
| Net Income | -226,257 |
| EBITDA | n/a |
| EBIT | -234,387 |
| Loss Per Share | -0.68 |
Balance Sheet
The company has 906 in cash and 352,411 in debt, with a net cash position of -351,505 or -1.02 per share.
| Cash & Cash Equivalents | 906 |
| Total Debt | 352,411 |
| Net Cash | -351,505 |
| Net Cash Per Share | -1.02 |
| Equity (Book Value) | -2.40M |
| Book Value Per Share | -7.08 |
| Working Capital | -2.31M |
Cash Flow
| Operating Cash Flow | -32,981 |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | 42,223 |
| Free Cash Flow | -32,981 |
| FCF Per Share | -0.10 |
Margins
| Gross Margin | 44.90% |
| Operating Margin | -7,807.69% |
| Pretax Margin | -7,538.04% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NRBP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -28.47% |
| Shareholder Yield | -28.47% |
| Earnings Yield | -176.86% |
| FCF Yield | -25.78% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 12, 2026. It was a reverse split with a ratio of 0.0005.
| Last Split Date | Aug 12, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.0005 |
Scores
NRBP has an Altman Z-Score of -228.61 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -228.61 |
| Piotroski F-Score | 5 |